Dr. Gershwin Theophilus Blyden, MD

Dr. Blyden practices at The Foundation for Sickle Cell Disease Research - Hollywood Sickle Cell Center of Excellence in Hollywood, Florida.

Dr. Blyden's NPI, 1851344014, was assigned on May 18, 2006. Dr. Blyden graduated from Yale School of Medicine in 1979. Dr. Blyden holds Florida license 0048415.

Dr. Blyden's primary practice is The Foundation for Sickle Cell Disease Research - Hollywood Sickle Cell Center of Excellence, at 1685 S State Road 7 Ste 4, Hollywood, FL 33023. The practice phone is (954) 397-3251.

Dr. Blyden's primary practice is The Foundation for Sickle Cell Disease Research - Hollywood Sickle Cell Center of Excellence in Hollywood, Florida. The medical group on file is Foundation for Sickle Cell Disease Research. Dmand AI also links Dr. Blyden to 1 more physician office, named with a free account. Dr. Blyden's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blyden practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Blyden's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Blyden is board certified in internal medicine by the American Board of Internal Medicine. Dr. Blyden is licensed in Florida.

Dmand AI lists acute mini-stroke (TIA), arthritis, cardiomyopathy, cerebrovascular disease, chronic anemia, chronic diabetes, chronic hypertension and chronic kidney disease among the conditions Dr. Blyden treats.

CMS data shows 40,846 Medicare services from Dr. Blyden across 28 procedure codes in 2024, for 82 Medicare patients. Medicare paid $386,751 for them. Every service was in an office.

CMS counts 82 Medicare patients who saw Dr. Blyden in 2024. The largest group is under 65, with 48 patients. 68% of them have high blood pressure, and 50% have high cholesterol. 71% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blyden's median patient age at 50, with 59% women.

In 2024, Dr. Blyden wrote 2,924 Medicare Part D claims for 208 patients. 87% of them were for generic drugs. CMS names the drug for 2,435 of them, across 65 drugs with 11 or more claims each, at $1,577,008 in total drug cost. In 2023, CMS named 2,717 claims across 70 drugs.

Dr. Blyden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blyden as offering telehealth.

Dmand AI links 29 papers to Dr. Blyden in 2018. The most frequent topics are Antipyrine, Half-Life and Kinetics. Dr. Blyden has published most often in Pharmacology. Dr. Blyden's most frequent co-authors are Pasquale W. Benedetto, MD, Lynn G. Feun, MD and Niramol Savaraj, MD.

CMS Open Payments shows 186 general payments to Dr. Blyden from 24 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 36% of the total. Vifor (International) Ltd. paid the most, $2,443.

Dmand AI lists 2 awards for Dr. Blyden, most recently Top Doctors:South Florida in 2012.

Dr. Blyden graduated from Yale School of Medicine in 1979.

Dr. Blyden is in network with 11 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.